Clinical Trial Update: Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update aiming to reduce severity of delayed graft function in recipients of a deceased donor kidney.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delaysed Graft Function

Snippet

Sponsor: Angion Biomedica Corp | Conditions: Delayed Graft Function | Phase 3 | Status: UNKNOWN